Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Stomach Neoplasms, Carcinoma, Merkel Cell, Neoplasms, Squamous Cell, Small Cell Lung Carcinoma

NCT05031065 2025-06-27

Prognostic Indicators for Radiation-induced Breast Fibrosis

Terminated

4 enrolled

Breast

Breast Neoplasms

Clinical Trials

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

TRANSCENDER

Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening

APAPI

RepriM

PRESSODOU

TSARINE

Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility

An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung Cancer

HeartPhone Cancer Survivors Trial 2019

Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors

Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer

Preventing Lymphedema in Axillary Lymph Node Dissection

Abemaciclib for Patients With Retinoblastoma-Positive, Triple Negative Metastatic Breast Cancer

Topical Dermaprazole for Radiation Dermatitis in Breast Cancer Patients (TOPAZ)

Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer

Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer

Breast-48

A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys

DWIBS

Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk

Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

ELPIS

PROTECT-COEUR

PROTECT-06-bis

Néo-APBI-01

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences

Decellularized, Whole Donor Nipple-Areola Complex Reconstruction Grafts

TrasTUCAN

OTT15-04

BIS-Program

Targeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the Breast

AXIL95

YASU Research Registry: For Young Adults With Cancer

CLODIS

3-D Super Resolution Ultrasound Microvascular Imaging

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors

Impact of Topical Tranexamic Acid in Breast Reconstruction

WI223281

A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer. NK-ACT-BC_2020

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

SMART-ER

CAR T Cells in Mesothelin-Expressing Breast Cancer

PROACT

AM-003

Prognostic Indicators for Radiation-induced Breast Fibrosis